We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry Efforts to Expand Insulin Access Lacking in Poorer Countries, Group Says
Industry Efforts to Expand Insulin Access Lacking in Poorer Countries, Group Says
The biggest insulin producers — Eli Lilly, Novo Nordisk and Sanofi — are falling short in their efforts to expand global access to the life-saving drug, claims a new report from the Access to Medicine Foundation, a nonprofit group.